Subject
Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine
Reference54 articles.
1. Immune checkpoint blockade: a common denominator approach to cancer therapy;Topalian;Cancer Cell,2015
2. The future of immune checkpoint therapy;Sharma;Science,2015
3. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer;Topalian;N. Engl. J. Med.,2012
4. Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy;Taube;Clin. Cancer Res.,2014
5. Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates;Brahmer;J. Clin. Oncol.,2010
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献